Your browser doesn't support javascript.
loading
Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study
Cui, Yuzhong; Du, Feng; Huang, Wei; Yin, Xiaoyang; Li, Baosheng.
Affiliation
  • Cui, Yuzhong; Tianjin Medical University Cancer Institute and Hospital. Tianjin. China
  • Du, Feng; Zibo Municipal Hospital. Department of Oncology. Zibo. China
  • Huang, Wei; Shandong First Medical University and Shandong Academy of Medical Sciences. Jinan. China
  • Yin, Xiaoyang; Shandong First Medical University and Shandong Academy of Medical Sciences. Jinan. China
  • Li, Baosheng; Shandong First Medical University and Shandong Academy of Medical Sciences. Jinan. China
Clin. transl. oncol. (Print) ; 25(2): 560-562, feb. 2023.
Article in En | IBECS | ID: ibc-215954
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Radiation-Sensitizing Agents / Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Limits: Humans Language: En Journal: Clin. transl. oncol. (Print) Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Radiation-Sensitizing Agents / Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Limits: Humans Language: En Journal: Clin. transl. oncol. (Print) Year: 2023 Document type: Article